New International Pharma Industry Leader Brings Prospect Of Change
By William New
Alicia Greenidge represents a change for the global pharmaceutical and biotechnology industry, but as she grows into her role as the head of the industry's international trade association, it is unclear whether there will be substantive changes on policy relating to intellectual property and public health. Key policy areas include counterfeit medicines and funding for research and development into diseases afflicting poor populations in ways that echo past industry approaches, but Greenidge brings a new focus on networking and negotiation.
